Citigroup’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277K Buy
175,078
+104,340
+148% +$176K ﹤0.01% 3842
2025
Q4
$118K Buy
70,738
+69,332
+4,931% +$120K ﹤0.01% 4259
2025
Q3
$2.38K Hold
1,406
﹤0.01% 5441
2025
Q2
$1.28K Sell
1,406
-126,696
-99% -$75.2K ﹤0.01% 5389
2025
Q1
$57.9K Buy
128,102
+6,249
+5% +$3.67K ﹤0.01% 4839
2024
Q4
$61.2K Buy
121,853
+11,664
+11% +$8.56K ﹤0.01% 5031
2024
Q3
$99.8K Buy
110,189
+74,095
+205% +$68.7K ﹤0.01% 4764
2024
Q2
$36K Buy
36,094
+10,241
+40% +$11.3K ﹤0.01% 4772
2024
Q1
$38.3K Buy
25,853
+2,022
+8% +$2.29K ﹤0.01% 4750
2023
Q4
$26K Sell
23,831
-109,220
-82% -$120K ﹤0.01% 4882
2023
Q3
$157K Sell
133,051
-25,720
-16% -$35K ﹤0.01% 3770
2023
Q2
$224K Sell
158,771
-304,113
-66% -$420K ﹤0.01% 3841
2023
Q1
$694K Sell
462,884
-14,290
-3% -$19.9K ﹤0.01% 2862
2022
Q4
$558K Buy
477,174
+341,193
+251% +$430K ﹤0.01% 3084
2022
Q3
$154K Buy
135,981
+131,050
+2,658% +$192K ﹤0.01% 3886
2022
Q2
$8K Sell
4,931
-4,106
-45% -$5.42K ﹤0.01% 5448
2022
Q1
$14K Sell
9,037
-26,570
-75% -$41.2K ﹤0.01% 5359
2021
Q4
$87K Sell
35,607
-102,251
-74% -$239K ﹤0.01% 4802
2021
Q3
$347K Buy
137,858
+126,195
+1,082% +$324K ﹤0.01% 3865
2021
Q2
$33K Buy
11,663
+3,527
+43% +$9.13K ﹤0.01% 5025
2021
Q1
$19K Buy
8,136
+2,245
+38% +$5.39K ﹤0.01% 5283
2020
Q4
$10K Hold
5,891
﹤0.01% 6948
2020
Q3
$6K Hold
5,891
﹤0.01% 6909
2020
Q2
$5K Sell
5,891
-31,219
-84% -$27.5K ﹤0.01% 7270
2020
Q1
$31K Buy
37,110
+2,935
+9% +$2.92K ﹤0.01% 6379
2019
Q4
$30K Buy
34,175
+18,577
+119% +$15.5K ﹤0.01% 6712
2019
Q3
$15K Sell
15,598
-16,733
-52% -$17.3K ﹤0.01% 6883
2019
Q2
$35K Sell
32,331
-2,117
-6% -$2.44K ﹤0.01% 6755
2019
Q1
$45K Buy
34,448
+5,933
+21% +$7.38K ﹤0.01% 6421
2018
Q4
$26K Sell
28,515
-4,601
-14% -$7.05K ﹤0.01% 6738
2018
Q3
$68K Buy
33,116
+451
+1% +$947 ﹤0.01% 6258
2018
Q2
$59K Buy
32,665
+1,726
+6% +$3.48K ﹤0.01% 6153
2018
Q1
$71K Buy
30,939
+15,052
+95% +$35.3K ﹤0.01% 5904
2017
Q4
$30K Buy
15,887
+12,845
+422% +$28K ﹤0.01% 6506
2017
Q3
$8K Buy
3,042
+1,870
+160% +$4.64K ﹤0.01% 6748
2017
Q2
$3K Sell
1,172
-1,972
-63% -$5.51K ﹤0.01% 6886
2017
Q1
$9K Sell
3,144
-78,259
-96% -$222K ﹤0.01% 6597
2016
Q4
$257K Buy
81,403
+73,455
+924% +$226K ﹤0.01% 5071
2016
Q3
$27K Sell
7,948
-1,770
-18% -$4.89K ﹤0.01% 6054
2016
Q2
$22K Sell
9,718
-45,361
-82% -$111K ﹤0.01% 6104
2016
Q1
$138K Buy
55,079
+33,998
+161% +$75.9K ﹤0.01% 5426
2015
Q4
$70K Buy
21,081
+20,860
+9,439% +$62.3K ﹤0.01% 5665
2015
Q3
$1K Sell
221
-1,020
-82% -$2.64K ﹤0.01% 7175
2015
Q2
$3K Sell
1,241
-2,808
-69% -$10.9K ﹤0.01% 6991
2015
Q1
$17K Sell
4,049
-9,102
-69% -$31.5K ﹤0.01% 6174
2014
Q4
$39K Buy
13,151
+9,663
+277% +$26.1K ﹤0.01% 5852
2014
Q3
$9K Buy
3,488
+2,736
+364% +$6.59K ﹤0.01% 6319
2014
Q2
$2K Sell
752
-6,320
-89% -$14.3K ﹤0.01% 6752
2014
Q1
$19K Sell
7,072
-15,053
-68% -$44.3K ﹤0.01% 6052
2013
Q4
$64K Buy
22,125
+21,598
+4,098% +$65.3K ﹤0.01% 5580
2013
Q3
$1K Sell
527
-244
-32% -$772 ﹤0.01% 6675
2013
Q2
$2K Buy
+771
New +$2.47K ﹤0.01% 6526

Other funds holding LCTX